HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages

Clinical and Experimental Immunology

Volumn 112, Issue 1, 1998, Pages 105-111

  Bergamini, A ^a   Bolacchi, F ^a   Faggioli, E ^a   Placido, R ^a   Vendetti, S ^a   Cappannoli, L ^a   Ventura, L ^a   Cerasari, G ^b   Uccella, I ^a   Andreoni, M ^a   Rocchi, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Colony stimulating factor; L 10; Lipopolysaccharide; Macrophage; Monocytes macrophages

Indexed keywords

CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COLONY FORMING UNIT M; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; RECOMBINANT PROTEINS;

EID: 15644367804     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00563.x     Document Type: Article

References (48)

1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-7.
2. + T cell showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type I infection. J Exp Med 1994; 180:489-95.
3. O'Garra A, Stapleton G, Dhar V et al. Production of cytokine by mouse B cells. B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2:821-6.
4. De Waal Malefyt R, Abrams J, Bennet B, Frigdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
5. Ralph P, Nakoinz I, Sampson-Joannes A et al. IL-10. T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992; 148:808-13.
6. Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-50.
7. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
8. Howard M, O'Garra A, Ishida H, de-Waal-Malefyt R, de Vries J. Biological properties of interleukin 10. J Clin Immunol 1992; 12:239-47.
9. Shearer GM, Clerici M. Abnormalities of immune regulation in human immunodeficiency virus infection. Pediatr Res 1993; 33:S71-S75.
10. Weiss RA. How does HIV cause AIDS? Sci 1993; 260:1273-8.
11. Maggi E, Macchia D, Parronchi P et al. Reduced production of interleukin 2 and interferon gamma and enhanced helper activity for IgG synthesis by cloned CD4 T cells from patients with AIDS. Eur J Immunol 1987; 17:1685-90.
12. Clerici M, Herkin FT, Venzon DJ, Hendrix GW, Wynn TA, Shearer GM. Changes in interleukin 2 and interleukin 4 production in asymptomatic human immunodeficiency virus seropositive individuals. J Clin Invest 1993; 91:789-93.
13. Diaz-Mitoma F, Kumar A, Karimi S et al. Expression of IL-10, IL-4 and interferon gamma in unstimulated and mitogen stimulated peripheral blood lymphocytes from HIV seropositive patients. Clin Exp Immunol 1995; 102:31-39.
14. Clerici M, Wynn TA, Berzofsky JA et al. Role of interleukin 10 in T helper dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93:768-75.
15. Graziosi C, Pantaleo G, Gantt KR et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-intected individuals Sci 1994; 265:248-51.
16. Ameglio F, Cordiali Fei P, Solmone M et al. Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 1994; 8:48-52.
17. McErlath MJ, Pruett JE, Chon ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 1989; 86:675-9.
18. Embretson J, Zupanic M, Rihas JL et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362:359-65.
19. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T-lymphotrophic virus type III infection of human alveolar macrophages. Blood 1986; 68:281-95.
20. Hoda SA, Gerber MA. Immunohistochemical studies of human immunodeficiency virus type I in liver tissues of patients with AIDS. Clin Pathol 1990; 93:452-8.
21. Koenig S, Gendelman HE, Orenstein JM et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Sci 1986; 233:1089-93.
22. Hagiwara E, Sacks T, Leitman-Klinman SF, Klinman DM. Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood. AIDS Res Hum Retrovir 1996; 12:127-33.
23. Borghi P, Fantuzzi L, Varano B et al. Induction of interleukin 10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol 1995; 69:1284-7.
24. Akridge RF, Oyafuso LKM, Reed SG. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994; 153:5782-9.
25. Yoo J, Chen H, Kraus T et al. Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol 1996; 157:1313-20.
26. Chehimi J, Ma X, Chouaib S et al. Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retrovir 1996; 12:1141-9.
27. Dereuddre-Bosquet N, Clayette P, Martin M et al. Lack of interleukin 10 expression in monocyte-derived macrophages in response to in vitro infection by HIV type 1 isolates. AIDS Res Hum Retrovir 1997; 13:961-6.
28. Chen BDM, Clark CR, Chou Th. Granulocyte/macrophage colony stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor. Blood 1988; 71:997-1002.
29. Ampel NM, Wing EJ, Waheed A, Shadduck RK. Stimulatory effects of purified macrophage colony stimulating factor on murine resident peritoneal macrophage. Cell Immunol 1986; 97:344-9.
30. Young DA, Lowe LD, Clark CS. Comparison of the effects of IL-3, granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicily. J Immunol 1990; 145:607-15.
31. Becker S, Warren MK, Haskill S. Colony stimulating factor-induced monocyte survival and differentiation into macrophages in serum free cultures. J Immunol 1987; 139:3703-9.
32. Gerrard TL, Jurgensen CH, Fauci AS. Differential effect of monoclonal anti DR antibody on monocytes in antigen-and mitogen-stimulated response: mechanisms of inhibition and relationship to interleukin 1 secretion. Cell Immunol 1983; 82:394-402.
33. Bergamini A, Capozzi M, Ghibelli L et al. Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells. J Clin Invest 1994; 93:2251.
34. Andreoni M, Sarmati L, Parisi SG, Ercoli L, Rocchi G. Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma. J Med Virol 1992; 38:207-13.
35. Karber G. Beitrag zur kollektiven Behandlung Pharmakologischer Reihenversuche. Arch Exp Pharmakol 1931; 162:480-3.
36. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991; 119:65-93.
37. Dentener MA, Bazil V, Von Asmuth EJU, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1992; 150:2885-91.
38. Crowe S, Mills J, McGrath MS. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophage. AIDS Res Hum Retrovir 1987; 3:135-41.
39. Gan H, Ruef C, Hall BF, Tobin E, Remold HG, Mellors JW. Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). Aids Res Hum Retrovir 1991; 7:671-9.
40. Koyanagi Y, O'Brien W, Zhao JQ, Golde DW, Gasson JC, Chen ISY. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Sci 1988; 241:1673-5.
41. Arenzana-Seisdedos F, Virelizier JF, Fiers W. Interferons as macrophage activating factors. III. Preferential effects of IFN-γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol 1985; 134:2444-7.
42. Arend WP, Gordon DF, Wood WM, Janson RW, Joslin FG, Jameel S. IL-1β production in cultured human monocytes is regulated at multiple levels. J Immunol 1989; 143:118-25.
43. Asakura E, Hanamura T, Umemura A, Yada K, Yamauchi T, Tanabe T. Effects of macrophage colony stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro. Immunobiol 1996; 195:300-13.
44. Furosawa S, Komatsu H, Saito K, Enokihara H, Hirose K, Shishido H. Effect of normal human serum on granulocyte colony formation by human bone marrow cells. J Clin Med 1978; 91:377-82.
45. Chan SH, Metcalf D, Stanley ER. Stimulation and inhibition by normal human serum of colony formation in vitro by human bone marrow cells. Br J Haematol 1971; 20:329-34.
46. Weiner LM, Li W, Holmes M et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma interferon: toxicity, monocytosis and clinical effect. Cancer Res 1994; 54:4084-90.
47. 2) production by HIV. J Immunol 1989; 142:531-6.
48. Merril JE, Koyangi Y, Chen ISY. Interleukin 1 and tumor necrosis factor-alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63:4404-8.